Trademarkia Logo

Australia

AU$
CIRVASQU
Accepted: In opposition period

Last updated on 23 Apr 2025

Owner Info

CeleCor Therapeutics, Inc.

1155 Camino Del Mar, Suite 481

Del Mar CA 92014, UNITED STATES OF AMERICA

Serial Number

2538560 filed on 13 Mar 2025

Correspondent

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.

600 Atlantic Avenue,

Boston MA 02210-2206,

UNITED STATES OF AMERICA

CIRVASQU

Classification Information


Class [005]
Pharmaceutical preparations and therapeutics for the treatment of cardiovascular disease.

Mark Details


Serial Number

2538560

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

13 Sept 2024

Mark Type

US

Legal History


Show more

Status DateAction Taken
23rd Apr 2025Application Accepted correspondence sent
22nd Apr 2025IP Right has been Examined
22nd Apr 2025IP Right Acceptance Published
22nd Apr 2025Status change to Accepted
11th Apr 2025Awaiting examination
11th Apr 2025Examination expedited
10th Apr 2025IP Right Filed Published
10th Apr 2025Status change to Published
10th Apr 2025Status change to Filed
10th Apr 2025Application Received